新型国家药品服务体系建设的构想  

Concepts for the Construction of a New National Drug Service System

作　　者：王健[1] 袁春平[1] 王浩[1] 张志荣[2] 张强[3] 陈桂良[4] 刘昌孝[5] 侯惠民[1] 杨胜利[6] 

机构地区：[1]药物制剂国家工程研究中心,上海201203 [2]四川大学华西药学院,成都610041 [3]北京大学药学院,北京100191 [4]上海市食品药品检验所,上海201203 [5]天津药物研究院,天津300193 [6]中国科学院上海生命科学研究院,上海200031

出　　处：《中国工程科学》2017年第2期62-67,共6页Strategic Study of CAE

基　　金：中国工程院咨询项目"我国全民健康与医药卫生事业发展战略研究"(2014-ZD-06)

摘　　要：我国现有药品服务体系可初步满足医疗卫生的基本需求,但在研发、生产、销售及使用的各领域中均存在一些突出问题。本研究通过文献检索、数据查询、专家咨询及专题讨论,对我国药品服务体系的现状进行调研,找准存在的问题,并提出建设新型国家药品服务体系的构想,旨在为我国人民提供质量优良、疗效可靠、价格合理、使用方便的药品,保障临床用药的有效性、安全性、可及性及合理性;同时,促进制药产业结构转型发展,推动我国从制药大国向制药强国的转变。Although the current drug service system can meet the fundamental needs of healthcare in China, outstanding issues exist in all service sectors, including research and development, manufacturing, marketing, and clinical use. Through a literature search, data queries, specialist consultation, and a panel discussion, this study investigated the current status of the drug service system and identified the main problems. We propose an idea for constructing a new national drug service system to provide drugs to the Chinese people that are of high quality, have a reliable therapeutic effect, come at a reasonable price, and exhibit good medical compliance, thus ensuring the efficacy, safety, availability, and reasonability of drugs for clinical use, as well as promoting a structural transformation of the pharmaceutical industry that will enable China to finally transition from a big country into a great power in the global pharmaceutical industry.

关 键 词：药品 服务体系 制药产业 监管 发展战略 

分 类 号：R944[医药卫生—药剂学]